Literature DB >> 7086696

Pharmacological analysis of the phencyclidine-like discriminative stimulus properties of narcotic derivatives in rats.

H E Shannon.   

Abstract

The purpose of the present experiments was to evaluate the phencyclidine (PCP)-like discriminative stimulus properties of narcotic derivatives in the rat. Rats were trained to discriminate between saline and 3.0 mg/kg of PCP in a two-choice, shock-avoidance procedure. PCP-like stimulus control of behavior was produced by (in order of relative molar potency): l-cyclazocine greater than PCP greater than dl-cyclazocine greater than SKF 10,047 greater than MeO-cyclazocine greater than dextrorphan greater than d-cyclazocine. Metazocine and levalorphan also occasioned appreciable percentages of PCP-appropriate responding. Ten other narcotic derivatives, including pentazocine and nalorphine, occasioned only saline-appropriate responding. Among enantiomeric pairs, levocyclazocine was more potent than dextrocyclazocine, and dextrorphan but not levorphanol produced PCP-like discriminative effects. The specific narcotic antagonist naloxone failed to antagonize these PCP-like effects but rather increased the relative potency of cyclazocine and "unmasked" PCP-like effects of higher doses of metazocine. These results demonstrate that PCP and selected narcotic derivatives have similar components of action which appear to be mediated by sigma receptors rather than receptors which subserve the characteristic opioid actions of narcotic analgesics.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7086696

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  16 in total

1.  Cross-tolerance and enhanced sensitivity to the response rate-decreasing effects of opioids with varying degrees of efficacy at the mu receptor.

Authors:  M J Picker; J Yarbrough
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

2.  Potentiation of disruptive effects of dextromethorphan by naloxone on fixed-interval performance in rats.

Authors:  T Taşkin
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

3.  Discriminative stimulus effects of spiradoline, a kappa-opioid agonist.

Authors:  S G Holtzman; L Cook; G F Steinfels
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

4.  Drug discrimination training with a single choice trial per session.

Authors:  A Tomie; E Loukas; I Stafford; L Peoples; G C Wagner
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

Review 5.  Trends in drug discrimination research analysed with a cross-indexed bibliography, 1982-1983.

Authors:  I P Stolerman; P J Shine
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

6.  Behavioural and electoencephalographic interactions between haloperidol and PCP/sigma ligands in the rat.

Authors:  S Sagratella; A Scotti de Carolis; A Pèzzola; P Popoli
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

Review 7.  Ketamine and phencyclidine: the good, the bad and the unexpected.

Authors:  D Lodge; M S Mercier
Journal:  Br J Pharmacol       Date:  2015-07-28       Impact factor: 8.739

8.  Evidence for multiple opiate receptor involvement in different phencyclidine-induced unconditioned behaviors in rats.

Authors:  B D Greenberg; D S Segal
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

9.  Effects of phencyclidine, haloperidol, and naloxone on fixed-interval performance in rats.

Authors:  G C Wagner; D B Masters; A Tomie
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

10.  Discriminative properties of phencyclidine in mice: generalization to ketamine and monohydroxy metabolites.

Authors:  L D Middaugh; J P Favara; W O Boggan; A J Stringer
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.